Ginkgo Bioworks Holdings, Inc. — Investor Relations & Filings

Ginkgo Bioworks Holdings, Inc. operates a horizontal platform for cell programming and synthetic biology. The company utilizes advanced automation, proprietary software, and data analytics in its biofoundries to design, build, and test engineered organisms for its partners. The platform's goal is to make programming cells as accessible as programming computers, thereby accelerating biotechnology research and development. Ginkgo serves a broad range of markets, including biopharmaceuticals, agriculture, food and nutrition, and industrial chemicals. Its services support the development of products such as novel therapeutics, sustainable agricultural solutions, and specialty ingredients. Additionally, the company provides biosecurity services for pathogen detection and public health response.